Prelude Therapeutics PRLD
NASDAQ PRLD
$3.96 +0.05 (+1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Total Current Liabilities (2019 - 2026)

Updated

Prelude Therapeutics (PRLD) reported Total Current Liabilities of $38.04 million for Q2 2026, up 81.9% from $20.91 million a year earlier but down 8.8% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Prelude Therapeutics posted Total Current Liabilities of $52.99 million, up 106.7% from FY2024.

  • Total Current Liabilities has increased for six consecutive years, with a five-year compound annual growth rate of 36.0% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $25.64 million in FY2024 (+17.5%), $21.83 million in FY2023 (+0.6%), $21.7 million in FY2022 (+13.0%) and $19.2 million in FY2021 (+68.8%).
  • Five-year quarterly Total Current Liabilities spans a low of $15.19 million in Q2 2023 and a high of $52.99 million in Q4 2025.
  • Year over year, Total Current Liabilities has now increased in each of the last three quarters, with growth averaging 41.5% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q1 2026 (growth of 110.8%); the low point was Q3 2023 (a decline of 21.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $41.72 million (Q1 2026), $52.99 million (Q4 2025) and $18.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - 38.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.04 Mn
Mar 31, 2026 41.72 Mn
Dec 31, 2025 52.99 Mn
Sep 30, 2025 18.19 Mn
Jun 30, 2025 20.91 Mn
Mar 31, 2025 19.79 Mn
Dec 31, 2024 25.64 Mn
Sep 30, 2024 22.22 Mn
Jun 30, 2024 23.34 Mn
Mar 31, 2024 17.64 Mn
Dec 31, 2023 21.83 Mn
Sep 30, 2023 16.89 Mn
Jun 30, 2023 15.19 Mn
Mar 31, 2023 19.66 Mn
Dec 31, 2022 21.70 Mn
Sep 30, 2022 21.56 Mn
Jun 30, 2022 15.81 Mn
Mar 31, 2022 16.07 Mn
Dec 31, 2021 19.20 Mn
Sep 30, 2021 19.66 Mn
API Access

Prelude Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PRLD&period=max&api_key=YOUR_API_KEY